Table 3.
EFS and OS rates in patients treated with HDC or SDC (International Prognostic Factors Study Group)
| 2-yr EFS | P value | 5-yr OS | P value | ||
|---|---|---|---|---|---|
| All patients (N=1594) | SDC | 28 % | <0.001 | 41 % | <0.001 |
| HDC | 50 % | 53 % | |||
| Very low risk (N=76) | SDC | 58 % | <0.001 | 64 % | <0.01 |
| HDC | 92 % | 89 % | |||
| Low risk (N=257) | SDC | 40 % | <0.001 | 66 % | 0.98 |
| HDC | 64 % | 64 % | |||
| Intermediate risk (N=646) | SDC | 32 % | <0.001 | 45 % | <0.001 |
| HDC | 53 % | 58 % | |||
| High risk (N=351) | SDC | 17 % | <0.001 | 23 % | <0.005 |
| HDC | 33 % | 35 % | |||
| Very high risk (N=105) | SDC | 2 % | <0.001 | 3 % | <0.001 |
| HDc | 22 % | 27 % | |||